Literature DB >> 25399800

Why do some recovered peripartum cardiomyopathy mothers experience heart failure with a subsequent pregnancy?

James D Fett1, Tina P Shah, Dennis M McNamara.   

Abstract

OPINION STATEMENT: After concerns about survival and recovery from peripartum cardiomyopathy (PPCM), the question commonly asked is, "Is it safe to have another pregnancy?" While important advances have been made in the past decade in the recognition and treatment of PPCM, we still do not know why some apparently recovered PPCM mothers have a relapse of heart failure in a subsequent pregnancy. Knowing that some risk for relapse is always present, careful monitoring of the post-PPCM pregnancy is currently the best way to enable earlier diagnosis with institution of effective evidence-based treatment. In that situation it is reassuring to observe that when a subsequent pregnancy begins with recovered left ventricular systolic function to echocardiographic ejection fraction ≥0.50, even with relapse, the response to treatment is good with much more favorable outcomes. On the other hand, beginning the subsequent pregnancy with echocardiographic ejection fraction <0.50 greatly increases the risk for less favorable outcomes. This article summarizes the current state of knowledge; addresses the important questions facing patients, their families, and caregivers; and identifies the need for a prospective multi-center study of women with post-PPCM pregnancies. The reality is that an estimated 10 % to 20 % of apparently recovered PPCM mothers are going to relapse in a post-PPCM pregnancy; but we do not yet know why. Nevertheless, the lowest risk for relapse is experienced by those who (1) recover to left ventricular ejection fraction 0.55 prior to another pregnancy; (2) have no deterioration of left ventricular ejection fraction after phasing out angiotensin-converting enzyme inhibitor/angiotensin-receptor blocker treatment following recovery; and perhaps, (3) demonstrate adequate contractile reserve on exercise echocardiography.

Entities:  

Year:  2015        PMID: 25399800     DOI: 10.1007/s11936-014-0354-x

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  29 in total

1.  Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy.

Authors:  U Elkayam; P P Tummala; K Rao; M W Akhter; I S Karaalp; O R Wani; A Hameed; I Gviazda; A Shotan
Journal:  N Engl J Med       Date:  2001-05-24       Impact factor: 91.245

2.  Brief communication: Outcomes of subsequent pregnancy after peripartum cardiomyopathy: a case series from Haiti.

Authors:  James D Fett; Len G Christie; Joseph G Murphy
Journal:  Ann Intern Med       Date:  2006-07-04       Impact factor: 25.391

3.  Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution.

Authors:  James D Fett; Len G Christie; Robert D Carraway; Joseph G Murphy
Journal:  Mayo Clin Proc       Date:  2005-12       Impact factor: 7.616

4.  Validation of a self-test for early diagnosis of heart failure in peripartum cardiomyopathy.

Authors:  James D Fett
Journal:  Crit Pathw Cardiol       Date:  2011-03

5.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

Authors:  John J V McMurray; Stamatis Adamopoulos; Stefan D Anker; Angelo Auricchio; Michael Böhm; Kenneth Dickstein; Volkmar Falk; Gerasimos Filippatos; Cândida Fonseca; Miguel Angel Gomez-Sanchez; Tiny Jaarsma; Lars Køber; Gregory Y H Lip; Aldo Pietro Maggioni; Alexander Parkhomenko; Burkert M Pieske; Bogdan A Popescu; Per K Rønnevik; Frans H Rutten; Juerg Schwitter; Petar Seferovic; Janina Stepinska; Pedro T Trindade; Adriaan A Voors; Faiez Zannad; Andreas Zeiher
Journal:  Eur Heart J       Date:  2012-05-19       Impact factor: 29.983

6.  Pregnancy and subsequent pregnancy outcomes in peripartum cardiomyopathy.

Authors:  Debasmita Mandal; Saroj Mandal; Dipankar Mukherjee; Subhash Chandra Biswas; Tapan Kumar Maiti; Nibedita Chattopadhaya; Biswakes Majumdar; Manotosh Panja
Journal:  J Obstet Gynaecol Res       Date:  2010-11-28       Impact factor: 1.730

Review 7.  Peripartum cardiomyopathy.

Authors:  Karen Sliwa; James Fett; Uri Elkayam
Journal:  Lancet       Date:  2006-08-19       Impact factor: 79.321

8.  Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function.

Authors:  M B Lampert; L Weinert; J Hibbard; C Korcarz; M Lindheimer; R M Lang
Journal:  Am J Obstet Gynecol       Date:  1997-01       Impact factor: 8.661

Review 9.  Earlier detection can help avoid many serious complications of peripartum cardiomyopathy.

Authors:  James D Fett
Journal:  Future Cardiol       Date:  2013-11

10.  Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia.

Authors:  Sarosh Rana; Camille E Powe; Saira Salahuddin; Stefan Verlohren; Frank H Perschel; Richard J Levine; Kee-Hak Lim; Julia B Wenger; Ravi Thadhani; S Ananth Karumanchi
Journal:  Circulation       Date:  2012-01-18       Impact factor: 29.690

View more
  1 in total

Review 1.  At the Heart of the Pregnancy: What Prenatal and Cardiovascular Genetic Counselors Need to Know about Maternal Heart Disease.

Authors:  Ana Morales; Dawn C Allain; Patricia Arscott; Emily James; Gretchen MacCarrick; Brittney Murray; Crystal Tichnell; Amy R Shikany; Sara Spencer; Sara M Fitzgerald-Butt; Jessica D Kushner; Christi Munn; Emily Smith; Katherine G Spoonamore; Harikrishna S Tandri; W Aaron Kay
Journal:  J Genet Couns       Date:  2017-03-10       Impact factor: 2.537

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.